LYRM03 is a ubenimex-derived aminopeptidase inhibitor that attenuates LPS-induced acute lung injury in mice. It functions by suppressing pro-inflammatory mediator expression and inhibiting MyD88-dependent TLR4 signaling in alveolar macrophages, highlighting its potential for sepsis-related lung injury research.
Molekulargewicht:
407.5
CAS Nummer:
[1820750-36-4]
Formel:
C21H33N3O5
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten